{"product_id":"understanding-bacterial-vaginosis-how-one-bacterium-gardnerella-vaginalis-starts-the-infection","title":"Understanding Bacterial Vaginosis: How One Bacterium (Gardnerella vaginalis) Starts the Infection","description":"\u003cp\u003eBacterial vaginosis (BV) is the most common cause of vaginal discharge and is linked to serious reproductive health complications, including preterm birth and increased risk of HIV and other sexually transmitted infections — yet its exact cause has been controversial for decades. This review article proposes a conceptual model showing that BV is actually initiated by the sexual transmission of a single pathogen, \u003cem\u003eGardnerella vaginalis\u003c\/em\u003e, which has the unique ability to attach to vaginal cells, form a protective biofilm, and outcompete the healthy lactobacilli that normally keep the vagina healthy. The researchers present decades of evidence, including fulfilled Koch's postulates, demonstrating that \u003cem\u003eG. vaginalis\u003c\/em\u003e is not part of the normal vaginal flora but rather a sexually transmitted pathogen that paves the way for other anaerobic bacteria to overgrow and cause the symptoms of BV.\u003c\/p\u003e\n\n\u003ch1\u003eUnderstanding Bacterial Vaginosis: How One Bacterium (\u003cem\u003eGardnerella vaginalis\u003c\/em\u003e) Starts the Infection\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eWhat Is Bacterial Vaginosis (BV)?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#methods\"\u003eHow the Researchers Developed This Model\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#microbiome\"\u003eThe Healthy Vaginal Microbiome: How It Normally Develops\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#female\"\u003eG. vaginalis in the Female Genital Tract\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#male\"\u003eG. vaginalis in the Male Genital Tract\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#adherence\"\u003eHow G. vaginalis Attaches to the Body's Cells\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#mechanisms\"\u003eThe Mechanisms of G. vaginalis Infection\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#symbiosis\"\u003eThe BV Syndrome: Symbiosis in the Vaginal Microbiome\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#genetic\"\u003eGenetic Diversity: Are There \"Good\" and \"Bad\" Strains?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#koch\"\u003eKoch's Postulates: Proof That G. vaginalis Causes BV\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#implications\"\u003eWhat This Means for Patients and Treatment\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eStudy Limitations\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eBV is initiated by sexual transmission of Gardnerella vaginalis, not by poor hygiene.\u003c\/li\u003e\n\u003cli\u003eG. vaginalis forms a protective biofilm and outcompetes healthy lactobacilli, allowing other anaerobes to overgrow.\u003c\/li\u003e\n\u003cli\u003eBV is linked to preterm birth and increased risk of HIV and other sexually transmitted infections.\u003c\/li\u003e\n\u003cli\u003eRecurrent BV may be due to reinfection from a partner or biofilm resistance to standard antibiotics.\u003c\/li\u003e\n\u003cli\u003eTreatment strategies that specifically target G. vaginalis and its biofilm should be tested to improve prevention and treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eWhat Is Bacterial Vaginosis (BV)?\u003c\/h2\u003e\n\n\u003cp\u003eBacterial vaginosis is the most prevalent cause of symptomatic vaginal discharge worldwide, affecting millions of women each year. It's not just an uncomfortable nuisance, though. BV is associated with serious complications of reproductive health, including preterm birth, as well as the acquisition or transmission of sexually transmitted infections (STIs), including human immunodeficiency virus (HIV) infection.\u003c\/p\u003e\n\n\u003cp\u003eDespite its prevalence and impact, the precise cause of BV has remained unknown for over 60 years. This lack of understanding has had real-world consequences: current treatment regimens and prevention strategies are inadequate, and recurrence rates remain frustratingly high.\u003c\/p\u003e\n\n\u003cp\u003eThe mystery dates back to 1955, when researchers Gardner and Dukes first wrote: \"We are prepared to present evidence that the vast majority of so-called 'non-specific' bacterial vaginitides constitute a specific infectious entity caused by a single etiological agent... We have assigned the name \u003cem\u003eHaemophilus vaginalis\u003c\/em\u003e to this newly isolated bacillus.\" This organism was later renamed \u003cem\u003eGardnerella vaginalis\u003c\/em\u003e.\u003c\/p\u003e\n\n\u003cp\u003eAt the heart of the controversy is a simple observation: BV is characterized by dramatic changes in the vaginal flora. A healthy vagina is dominated by \u003cstrong\u003elactobacilli\u003c\/strong\u003e (beneficial bacteria that produce hydrogen peroxide), but in BV, these protective bacteria drop dramatically and are replaced by \u003cem\u003eGardnerella vaginalis\u003c\/em\u003e and a marked increase in strictly anaerobic bacteria (bacteria that grow without oxygen).\u003c\/p\u003e\n\n\u003cp\u003eThis review, published in \u003cem\u003eThe Journal of Infectious Diseases\u003c\/em\u003e, aims to settle the debate by presenting a clear conceptual model for how BV develops — a model that puts \u003cem\u003eG. vaginalis\u003c\/em\u003e at the center as the initiating pathogen.\u003c\/p\u003e\n\n\u003ch2 id=\"methods\"\u003eHow the Researchers Developed This Model\u003c\/h2\u003e\n\n\u003cp\u003eThis was not a traditional clinical trial or laboratory experiment. Instead, the authors conducted a comprehensive review of past and current research spanning more than 50 years of published studies. They examined evidence from epidemiology (how BV spreads in populations), microbiology (how bacteria behave in the lab), genomics (the genetic makeup of bacteria), and clinical studies (how BV presents in patients).\u003c\/p\u003e\n\n\u003cp\u003eBy synthesizing this vast body of evidence, they developed a \u003cstrong\u003econceptual model\u003c\/strong\u003e for the pathogenesis (disease development) of BV. Their model integrates findings on how the vaginal microbiome develops from birth, how \u003cem\u003eG. vaginalis\u003c\/em\u003e is transmitted sexually, how it adheres to and invades vaginal tissue, how it forms biofilms, and how it interacts with other vaginal bacteria to produce the full syndrome of BV.\u003c\/p\u003e\n\n\u003cp\u003eThe epidemiology of BV strongly indicates that it is acquired via sexual transmission — a key pillar of the model presented here.\u003c\/p\u003e\n\n\u003ch2 id=\"microbiome\"\u003eThe Healthy Vaginal Microbiome: How It Normally Develops\u003c\/h2\u003e\n\n\u003cp\u003eTo understand how BV happens, it helps to understand what a healthy vagina looks like. The vaginal flora is acquired shortly after birth from maternal and environmental sources.\u003c\/p\u003e\n\n\u003cp\u003eIn a landmark study of prepubertal girls, Hill and colleagues demonstrated the presence of anaerobic organisms in the vaginal fluid of the majority of girls, yet they were unable to demonstrate the presence of \u003cem\u003eG. vaginalis\u003c\/em\u003e by culture — even though it was specifically sought. This finding is important: if \u003cem\u003eG. vaginalis\u003c\/em\u003e were a normal part of the vaginal flora, it should be present in girls before puberty too, but it is not.\u003c\/p\u003e\n\n\u003cp\u003eAt puberty, with the production of \u003cstrong\u003eestrogen\u003c\/strong\u003e, the vaginal flora changes to lactobacillus predominance. Estrogen promotes the deposition of \u003cstrong\u003eglycogen\u003c\/strong\u003e (a stored form of sugar) in the vaginal epithelium (the lining of the vagina). This glycogen is used as a food source by the saccharolytic (sugar-fermenting) lactobacilli. The subsequent creation of \u003cstrong\u003elactic acid\u003c\/strong\u003e as their metabolic end product lowers the vaginal pH to below 4.5, creating an acidic environment that is hostile to many harmful bacteria.\u003c\/p\u003e\n\n\u003cp\u003eIn addition, the growth of lactobacilli increases the \u003cstrong\u003ereduction-oxidation (redox) potential\u003c\/strong\u003e of the vagina — a measure of the electron activity in the environment — which inhibits the growth of indigenous anaerobes (bacteria that thrive without oxygen).\u003c\/p\u003e\n\n\u003cp\u003eIn short: the healthy vagina is acidic, dominated by lactobacilli, and actively suppresses anaerobic bacteria. \u003cem\u003eG. vaginalis\u003c\/em\u003e is not part of this healthy picture.\u003c\/p\u003e\n\n\u003ch2 id=\"female\"\u003eG. vaginalis in the Female Genital Tract\u003c\/h2\u003e\n\n\u003cp\u003eEpidemiologic data strongly support the sexual transmission of \u003cem\u003eG. vaginalis\u003c\/em\u003e. The bacterium has been recovered from vaginal fluid in close to \u003cstrong\u003e100% of women with clinically diagnosed BV\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eOther frequently identified BV-associated bacteria, recovered at variable rates in the vaginal microbiome, include genital mycoplasmas and various strict anaerobes, including species of BVAB1, BVAB2, BVAB3, \u003cem\u003eAtopobium\u003c\/em\u003e, \u003cem\u003eLeptotrichia\u003c\/em\u003e, \u003cem\u003eMegasphaera\u003c\/em\u003e, \u003cem\u003ePrevotella\u003c\/em\u003e, and \u003cem\u003eDialister\u003c\/em\u003e. However, the assortment of strict anaerobes found in individuals with BV is heterogeneous — different women harbor different combinations.\u003c\/p\u003e\n\n\u003cp\u003eSeveral published studies have detected \u003cem\u003eG. vaginalis\u003c\/em\u003e in women who did not meet the clinical criteria for BV. For example, Teixeira et al found \u003cem\u003eG. vaginalis\u003c\/em\u003e in only \u003cstrong\u003e17.6% of \"healthy\" women\u003c\/strong\u003e without a clinical diagnosis of BV, but notably, there was no documentation that these women had none of the Amsel criteria (the standard clinical diagnostic criteria) or an optimal Nugent score of 0–3 (the standard microscopic scoring system). Similarly, Burton et al reported \u003cem\u003eG. vaginalis\u003c\/em\u003e present in \u003cstrong\u003e19% of women without BV\u003c\/strong\u003e but provided no Nugent score at all.\u003c\/p\u003e\n\n\u003cp\u003eThe authors argue that finding \u003cem\u003eG. vaginalis\u003c\/em\u003e in women without clinical evidence of BV — or possibly with intermediate flora (Nugent scores of 4–6, which meet neither the definition of BV nor normal flora) — likely represents \u003cstrong\u003easymptomatic infection\u003c\/strong\u003e, just as is seen with all sexually transmitted diseases.\u003c\/p\u003e\n\n\u003cp\u003eAs the authors put it: \"If \u003cem\u003eG. vaginalis\u003c\/em\u003e were a part of the normal vaginal flora, one would expect it to be present in all women and in prepubertal girls as well.\" It is not. The specific host-pathogen interactions that limit the virulence of the colonizing pathogen in these asymptomatic cases are still poorly understood.\u003c\/p\u003e\n\n\u003ch2 id=\"male\"\u003eG. vaginalis in the Male Genital Tract\u003c\/h2\u003e\n\n\u003cp\u003eFor a sexually transmitted infection to be credible, the pathogen must be found in men as well. Indeed, \u003cem\u003eG. vaginalis\u003c\/em\u003e has been recovered from the urethra and from seminal fluid in several studies. The presence of BV-related microorganisms in the male genital tract suggests a possible reservoir and supports the theory of sexual transmission of BV.\u003c\/p\u003e\n\n\u003cp\u003eSome researchers had hypothesized that semen itself — because of its alkaline (basic) properties — might alter the acidic pH of the vagina and lead to BV. However, documented sexual transmission of BV without exposure to semen in a heterosexual couple strongly suggests that it is not the semen itself that contributes to the development of BV, but rather the microbes transmitted via sexual activity. This is further supported by the apparent sexual transmission of BV among women who have sex with women (WSW) only.\u003c\/p\u003e\n\n\u003cp\u003eUsing sophisticated sequence variation techniques, Eren et al were able to show that \u003cstrong\u003esexual partners shared the same strains of \u003cem\u003eG. vaginalis\u003c\/em\u003e\u003c\/strong\u003e — a powerful piece of evidence for sexual transmission.\u003c\/p\u003e\n\n\u003cp\u003eWhere does \u003cem\u003eG. vaginalis\u003c\/em\u003e live in men? Insight comes from a study of the microbiome of adolescent boys. Nelson et al found \u003cem\u003eG. vaginalis\u003c\/em\u003e in \u003cstrong\u003e28% of urine samples\u003c\/strong\u003e but failed to detect it in samples from the coronal sulcus (the groove behind the head of the penis). This makes biological sense: in females, BV is an infection of the \u003cstrong\u003esquamous epithelium\u003c\/strong\u003e (flat, scale-like cells), not the columnar epithelium of the cervix. The male genital tract's only squamous epithelium is the distal urethra.\u003c\/p\u003e\n\n\u003cp\u003eHolst showed that BV-related organisms, including \u003cem\u003eG. vaginalis\u003c\/em\u003e, seem to transiently colonize male partners of women with BV. As with \u003cem\u003eTrichomonas vaginalis\u003c\/em\u003e in men (another pathogen that infects the squamous epithelium of the vagina), there is probably a high spontaneous resolution rate in men due to the inhospitable environment of the distal urethra.\u003c\/p\u003e\n\n\u003cp\u003eBV may be more common among WSW than in heterosexual women. Sexual exchange of infected vaginal fluid may be a more efficient mechanism for transmission between WSW than the behaviors that occur during heterosexual sex — which would account for the higher prevalence of BV in this population.\u003c\/p\u003e\n\n\u003ch2 id=\"adherence\"\u003eHow G. vaginalis Attaches to the Body's Cells\u003c\/h2\u003e\n\n\u003cp\u003eOnce transmitted, how does \u003cem\u003eG. vaginalis\u003c\/em\u003e actually start an infection? Examination of vaginal biopsy specimens demonstrates that BV is a \u003cstrong\u003ebiofilm community\u003c\/strong\u003e adherent to the vaginal epithelium — and \u003cem\u003eG. vaginalis\u003c\/em\u003e is the \u003cstrong\u003epredominant component\u003c\/strong\u003e of that biofilm mass.\u003c\/p\u003e\n\n\u003cp\u003eThe initial steps of establishing infection include three critical capabilities:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAdherence\u003c\/strong\u003e to host receptor sites on the vaginal cells\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProduction of cytotoxic substances\u003c\/strong\u003e (toxins that damage host cells) specific for human cells\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBiofilm formation\u003c\/strong\u003e (creating a protective community of bacteria)\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eIn the case of \u003cem\u003eG. vaginalis\u003c\/em\u003e, production of \u003cstrong\u003evaginolysin\u003c\/strong\u003e — a cholesterol-dependent cytolysin (a toxin that punches holes in cells) — is species-specific for human cells. Vaginolysin encodes a pore-forming toxin that binds to the \u003cstrong\u003eCD59\u003c\/strong\u003e human complement regulatory molecule (a protein that normally protects cells from the immune system's \"complement\" attack). This cytotoxin assists in the initial adherence of \u003cem\u003eG. vaginalis\u003c\/em\u003e to host epithelial cells.\u003c\/p\u003e\n\n\u003cp\u003eResearchers have recently compared the virulence factors of \u003cem\u003eG. vaginalis\u003c\/em\u003e against other BV-associated bacteria. A key study by Patterson et al examined adherence, biofilm formation, and cytotoxicity in the lab for \u003cem\u003eG. vaginalis\u003c\/em\u003e strains isolated from women with BV, as well as other BV-associated bacteria including \u003cem\u003eAtopobium\u003c\/em\u003e, \u003cem\u003ePrevotella\u003c\/em\u003e, and \u003cem\u003eMobiluncus\u003c\/em\u003e. The results were striking: \u003cstrong\u003eonly \u003cem\u003eG. vaginalis\u003c\/em\u003e demonstrated all 3 virulence factors.\u003c\/strong\u003e The authors suggested that the other organisms may be relatively avirulent opportunists that colonize after the infection has been initiated by \u003cem\u003eG. vaginalis\u003c\/em\u003e.\u003c\/p\u003e\n\n\u003cp\u003eFurthermore, recent work by Machado et al found that, in the lab, among BV-associated bacteria, \u003cem\u003eG. vaginalis\u003c\/em\u003e had the \u003cstrong\u003egreatest capacity to adhere to epithelial cells\u003c\/strong\u003e even in the presence of \u003cem\u003eLactobacillus crispatus\u003c\/em\u003e — one of the most protective species of lactobacilli found in healthy vaginas.\u003c\/p\u003e\n\n\u003ch2 id=\"mechanisms\"\u003eThe Mechanisms of G. vaginalis Infection\u003c\/h2\u003e\n\n\u003cp\u003eSubsequent to initial adherence to the host cell, the invading bacteria multiply and may produce a biofilm community as a means of future survival. Biofilm production is critical to the survival of \u003cem\u003eG. vaginalis\u003c\/em\u003e in the vagina. \u003cstrong\u003eSialidase\u003c\/strong\u003e, an enzyme produced by some strains of \u003cem\u003eG. vaginalis\u003c\/em\u003e, may enhance the production of biofilm through its \u003cstrong\u003emucinase activity\u003c\/strong\u003e (breaking down the protective mucus layer of the vagina).\u003c\/p\u003e\n\n\u003cp\u003eLaboratory studies have shown that biofilms of \u003cem\u003eG. vaginalis\u003c\/em\u003e are \u003cstrong\u003efar more tolerant of lactic acid and hydrogen peroxide\u003c\/strong\u003e (the very substances lactobacilli use to keep the vagina healthy) than are free-floating (planktonic) forms of \u003cem\u003eG. vaginalis\u003c\/em\u003e. This means once the bacteria form a biofilm, they become much harder for the body's natural defenses — and for antibiotics — to eliminate.\u003c\/p\u003e\n\n\u003cp\u003eOnce this critical mass of bacteria is present, \u003cstrong\u003equorum sensing\u003c\/strong\u003e (or bacterial \"cross-talk\") occurs. This is a sophisticated communication system that allows bacteria to coordinate their behavior as a community, effectively managing their new territory. Quorum sensing allows the bacteria to act together, turning on genes that help them survive and thrive.\u003c\/p\u003e\n\n\u003cp\u003eAt the same time, it is necessary for the invading pathogens to engage in \"chemical warfare\" with the native species. In the case of BV, the native species is lactobacilli. Research has shown that:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eCertain species of lactobacilli can produce inhibitory compounds (\u003cstrong\u003ebacteriocins\u003c\/strong\u003e) that are active against \u003cem\u003eG. vaginalis\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003eConversely, \u003cem\u003eG. vaginalis\u003c\/em\u003e produces bacteriocins that are active against lactobacilli in the lab\u003c\/li\u003e\n  \u003cli\u003e\n\u003cem\u003eG. vaginalis\u003c\/em\u003e also demonstrates \u003cstrong\u003eantibiosis\u003c\/strong\u003e (antagonistic interactions) via other, undetermined mechanisms\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eBack in 1991, Naggy et al published their work on antibiosis among vaginal organisms and concluded: \"It is probable that the growth inhibition of lactobacilli caused by certain strains of \u003cem\u003eG. vaginalis\u003c\/em\u003e is one of the first steps in the change in flora characteristic of BV.\" This statement from over 30 years ago remains a cornerstone of the current model.\u003c\/p\u003e\n\n\u003cp\u003eEvidence for direct competition between lactobacilli and \u003cem\u003eG. vaginalis\u003c\/em\u003e can be demonstrated from daily vaginal Gram stains of women with intermediate vaginal flora. In these women, lactobacilli and \u003cem\u003eG. vaginalis\u003c\/em\u003e visibly alternate as the dominant organism throughout the menstrual cycle.\u003c\/p\u003e\n\n\u003cp\u003eNotably, \u003cem\u003eG. vaginalis\u003c\/em\u003e dominates \u003cstrong\u003eat the time of menses\u003c\/strong\u003e (menstrual bleeding), suggesting competition for \u003cstrong\u003eiron\u003c\/strong\u003e as a substrate for the bacteria. It is known that heme (the iron-containing component of blood) favors the growth of proteolytic organisms, such as \u003cem\u003eG. vaginalis\u003c\/em\u003e. The observed fluctuations in the levels of lactobacilli and \u003cem\u003eG. vaginalis\u003c\/em\u003e during the cycle most likely represent competition for resources between these two groups of bacteria.\u003c\/p\u003e\n\n\u003ch2 id=\"symbiosis\"\u003eThe BV Syndrome: Symbiosis in the Vaginal Microbiome\u003c\/h2\u003e\n\n\u003cp\u003eAfter \u003cem\u003eG. vaginalis\u003c\/em\u003e establishes itself, a cascade of events unfolds. \u003cem\u003eG. vaginalis\u003c\/em\u003e, as a \u003cstrong\u003efacultative anaerobe\u003c\/strong\u003e (able to survive with or without oxygen), can tolerate the relatively high oxidation-reduction (redox) potential of a healthy vaginal microbiome — unlike strict anaerobes.\u003c\/p\u003e\n\n\u003cp\u003eSimilar to facultative anaerobes involved in the initiation of oral diseases (like gum disease), \u003cem\u003eG. vaginalis\u003c\/em\u003e begins the process of creating a \u003cstrong\u003elower redox potential\u003c\/strong\u003e — a chemical environment that is then suitable for the overgrowth of strict anaerobes, which are normally present in very low numbers.\u003c\/p\u003e\n\n\u003cp\u003eBut \u003cem\u003eG. vaginalis\u003c\/em\u003e doesn't just change the environment; it actively feeds the anaerobes. Here's how the symbiotic relationship works:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cem\u003eG. vaginalis\u003c\/em\u003e is a \u003cstrong\u003eproteolytic bacterium\u003c\/strong\u003e (protein-digesting) that produces \u003cstrong\u003eamino acids\u003c\/strong\u003e through its metabolism\u003c\/li\u003e\n  \u003cli\u003e\n\u003cem\u003ePrevotella bivia\u003c\/em\u003e, a strict anaerobe, uses these amino acids as its fuel source\u003c\/li\u003e\n  \u003cli\u003eAs \u003cem\u003eP. bivia\u003c\/em\u003e consumes the amino acids, it produces \u003cstrong\u003eammonia\u003c\/strong\u003e as a byproduct\u003c\/li\u003e\n  \u003cli\u003e\n\u003cem\u003eG. vaginalis\u003c\/em\u003e then uses that ammonia for its own growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThis creates a two-way feeding loop between \u003cem\u003eG. vaginalis\u003c\/em\u003e and the anaerobes. Moreover, this symbiotic relationship with the production of ammonia would cause a shift to a more \u003cstrong\u003ealkaline pH\u003c\/strong\u003e (less acidic), which is inhospitable to lactobacilli.\u003c\/p\u003e\n\n\u003cp\u003eIn vitro work has confirmed this: the addition of anaerobes to a \u003cem\u003eG. vaginalis\u003c\/em\u003e biofilm \u003cstrong\u003eenhances the growth of \u003cem\u003eG. vaginalis\u003c\/em\u003e\u003c\/strong\u003e. This synergistic relationship is responsible for the microbiological findings that define BV, as well as the typical clinical vaginal signs:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\"Clue cells\"\u003c\/strong\u003e — sloughing of vaginal epithelial cells coated with bacteria, visible under a microscope\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAmine odor\u003c\/strong\u003e — the classic fishy smell resulting from metabolic by-products of the increased numbers of BV-associated anaerobes\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"genetic\"\u003eGenetic Diversity: Are There \"Good\" and \"Bad\" Strains?\u003c\/h2\u003e\n\n\u003cp\u003eNot all \u003cem\u003eG. vaginalis\u003c\/em\u003e may be equally dangerous. Genomic sequencing has recently shown differences in virulence factors among strains of \u003cem\u003eG. vaginalis\u003c\/em\u003e.\u003c\/p\u003e\n\n\u003cp\u003eHarwich et al examined virulence factors for a strain of \u003cem\u003eG. vaginalis\u003c\/em\u003e from a woman with BV and another from a woman without BV. They found \u003cstrong\u003eimpaired adherence in the non-BV isolate\u003c\/strong\u003e and suggested that there may be both commensal (harmless) and pathogenic (disease-causing) strains of \u003cem\u003eG. vaginalis\u003c\/em\u003e.\u003c\/p\u003e\n\n\u003cp\u003eHowever, the authors of this review note an important caveat: as in other studies, there is no mention of the Amsel criteria or Gram stain characteristics of the woman without BV. It's possible she had intermediate flora or asymptomatic infection. Furthermore, this type of work needs to be replicated with multiple isolates before firm conclusions can be drawn.\u003c\/p\u003e\n\n\u003cp\u003eA recent comparative genomic analysis of \u003cstrong\u003e17 clinical isolates\u003c\/strong\u003e of \u003cem\u003eG. vaginalis\u003c\/em\u003e suggested that the species can be subdivided into \u003cstrong\u003e4 distinct clades\u003c\/strong\u003e (genetic groups) — or perhaps that there may even be multiple separate species of \u003cem\u003eG. vaginalis\u003c\/em\u003e. Ahmed et al found that the degree of diversity among the strains was \u003cstrong\u003eexceptionally high for a single species\u003c\/strong\u003e — remarkable genetic variety that may explain why some women develop symptomatic BV while others carry the organism without symptoms.\u003c\/p\u003e\n\n\u003ch2 id=\"koch\"\u003eKoch's Postulates: Proof That G. vaginalis Causes BV\u003c\/h2\u003e\n\n\u003cp\u003eOne of the most powerful arguments in favor of \u003cem\u003eG. vaginalis\u003c\/em\u003e as the cause of BV comes from \u003cstrong\u003eKoch's postulates\u003c\/strong\u003e — the gold standard criteria for proving a causal relationship between a microbe and a disease. Developed in 1884, these four conditions must be met:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003eThe microorganism must be found in abundance in all organisms suffering from the disease and not present in those without it\u003c\/li\u003e\n  \u003cli\u003eThe microorganism must be isolated from a diseased organism and grown in pure culture\u003c\/li\u003e\n  \u003cli\u003eThe cultured microorganism should cause disease when introduced into a healthy organism\u003c\/li\u003e\n  \u003cli\u003eThe microorganism must be reisolated from the inoculated, diseased experimental host and identified as being identical to the original specific causative agent\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eIn the case of \u003cem\u003eG. vaginalis\u003c\/em\u003e as the causative agent for BV, the authors argue these postulates have been fulfilled:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cem\u003eG. vaginalis\u003c\/em\u003e is found in \u003cstrong\u003enearly 100% of cases of BV\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eIt is isolated as the \u003cstrong\u003epredominant bacteria\u003c\/strong\u003e from women with BV, along with small amounts of indigenous vaginal flora\u003c\/li\u003e\n  \u003cli\u003eMost importantly, \u003cstrong\u003eCriswell et al caused clinical BV in healthy women\u003c\/strong\u003e who had negative cultures for \u003cem\u003eG. vaginalis\u003c\/em\u003e and no clinical signs of BV, by vaginal inoculation with a pure culture of \u003cem\u003eG. vaginalis\u003c\/em\u003e in its logarithmic growth phase\u003c\/li\u003e\n  \u003cli\u003eThey then \u003cstrong\u003ereisolated \u003cem\u003eG. vaginalis\u003c\/em\u003e\u003c\/strong\u003e from these women after the initiation of BV\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eTo address the objection that \u003cem\u003eG. vaginalis\u003c\/em\u003e has been isolated from women not meeting the Amsel criteria for BV, the authors point out that this does not mean those women are without disease. In many instances, the causative organism is present in the host but not causing overt disease — just as with asymptomatic carriage of STIs and gastrointestinal pathogens such as \u003cem\u003eSalmonella typhi\u003c\/em\u003e (the cause of typhoid fever).\u003c\/p\u003e\n\n\u003ch2 id=\"implications\"\u003eWhat This Means for Patients and Treatment\u003c\/h2\u003e\n\n\u003cp\u003eThis conceptual model has profound implications for how BV should be understood, prevented, and treated. If BV is truly initiated by the sexual transmission of \u003cem\u003eG. vaginalis\u003c\/em\u003e, then:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePrevention strategies\u003c\/strong\u003e should focus on preventing transmission of this specific pathogen, much like we prevent transmission of other STIs\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTreatment strategies\u003c\/strong\u003e should be specifically designed to eliminate \u003cem\u003eG. vaginalis\u003c\/em\u003e and its biofilm, rather than just addressing the overgrown anaerobes that cause symptoms\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePartner treatment\u003c\/strong\u003e may need to be reconsidered — as with any STI, treating only the index patient may lead to reinfection from an untreated partner\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBiofilm-targeted therapies\u003c\/strong\u003e are needed, since \u003cem\u003eG. vaginalis\u003c\/em\u003e biofilms are far more tolerant of lactobacilli's natural defenses (lactic acid and hydrogen peroxide) than free-floating bacteria — a finding that likely extends to antibiotic tolerance as well\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe authors conclude: \"BV is an important public health issue, yet its pathogenesis remains controversial. Its epidemiology strongly favors the hypothesis that it is a sexually transmitted infection. A significant body of data supports the pathogenicity of \u003cem\u003eG. vaginalis\u003c\/em\u003e. Studies have confirmed that it is the dominant component of the BV biofilm, strongly suggesting that other bacteria in the biofilm are opportunistic secondary intruders.\"\u003c\/p\u003e\n\n\u003cp\u003eThe presence of virulence factors in \u003cem\u003eG. vaginalis\u003c\/em\u003e, shown to be present over 30 years ago, has been recently confirmed by several studies. The authors recommend that \"prevention and treatment strategies specifically for \u003cem\u003eG. vaginalis\u003c\/em\u003e should be tested to determine their efficacy in decreasing rates of BV and its complications.\"\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eStudy Limitations\u003c\/h2\u003e\n\n\u003cp\u003eAs a review article proposing a conceptual model, this paper has inherent limitations that patients should understand:\u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003eThe model is based on synthesis of existing research rather than new experimental data\u003c\/li\u003e\n  \u003cli\u003eSome studies cited did not rigorously define \"normal\" vaginal flora, making it difficult to interpret findings of \u003cem\u003eG. vaginalis\u003c\/em\u003e in asymptomatic women\u003c\/li\u003e\n  \u003cli\u003eThe genetic diversity studies suggesting \"commensal\" versus \"pathogenic\" strains of \u003cem\u003eG. vaginalis\u003c\/em\u003e have not been replicated with multiple isolates\u003c\/li\u003e\n  \u003cli\u003eThe specific host-pathogen interactions that limit virulence in asymptomatic carriers remain poorly understood\u003c\/li\u003e\n  \u003cli\u003eWhile Koch's postulates have been fulfilled for \u003cem\u003eG. vaginalis\u003c\/em\u003e alone, the contribution of the complex polymicrobial community in established BV is not fully explained by this model alone\u003c\/li\u003e\n  \u003cli\u003eThe authors did not disclose any conflicts of interest, and the paper underwent standard peer review\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients\u003c\/h2\u003e\n\n\u003cp\u003eBased on this research, here's what patients should know and consider:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBV is not a \"normal\" condition.\u003c\/strong\u003e It is an infection, and the leading evidence suggests it is sexually transmitted — not caused by poor hygiene, as was once believed.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eRecurrent BV may be related to reinfection.\u003c\/strong\u003e If you have a regular partner, it may be worth discussing BV with your healthcare provider as a potentially sexually transmitted condition that might merit partner evaluation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWomen who have sex with women are at increased risk.\u003c\/strong\u003e BV is more common in WSW, likely because exchanging vaginal fluid is an efficient transmission route. This has implications for safer-sex practices between female partners.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCurrent treatments may be incomplete.\u003c\/strong\u003e Because \u003cem\u003eG. vaginalis\u003c\/em\u003e forms a protective biofilm that standard antibiotics may not fully penetrate, recurrence is common. If your BV keeps coming back, ask your doctor about biofilm-disrupting strategies or extended treatment regimens.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThe health implications go beyond discomfort.\u003c\/strong\u003e BV is linked to preterm birth and increased risk of HIV and other STIs. Treating and preventing BV is not just about symptom relief — it's about protecting your overall reproductive health.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk your provider about the evidence.\u003c\/strong\u003e Not all healthcare providers are aware of the latest research on \u003cem\u003eG. vaginalis\u003c\/em\u003e and biofilms. Bringing printed information from reputable sources can help facilitate a more informed conversation about your treatment options.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eUltimately, this review makes a compelling case that BV is not a vague \"imbalance\" of vaginal bacteria, but a specific infectious disease caused by a single initiating pathogen — \u003cem\u003eGardnerella vaginalis\u003c\/em\u003e — with all the public health implications that come with that designation.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat causes bacterial vaginosis (BV)?\u003c\/h3\u003e\n\u003cp\u003eBV is triggered by sexual transmission of a single bacterium, Gardnerella vaginalis. It attaches to vaginal cells, creates a protective biofilm, and outcompetes healthy lactobacilli. Other anaerobic bacteria then overgrow, causing the symptoms of BV. This is a specific infection, not just a vague imbalance.\u003c\/p\u003e\n\u003ch3\u003eIs BV sexually transmitted?\u003c\/h3\u003e\n\u003cp\u003eYes, strong evidence indicates BV is sexually transmitted. The bacteria G. vaginalis is found in the male genital tract, sexual partners often share the same strain, and BV occurs in women who have sex with women. Even transmission without semen exposure has been documented.\u003c\/p\u003e\n\u003ch3\u003eWhy does my BV keep coming back after treatment?\u003c\/h3\u003e\n\u003cp\u003eG. vaginalis forms a biofilm that is much more tolerant of natural defenses like lactic acid and hydrogen peroxide, and likely also more tolerant of antibiotics. Recurrent BV may also result from reinfection by an untreated partner. Ask your doctor about biofilm-disrupting strategies or extended treatment regimens.\u003c\/p\u003e\n\u003ch3\u003eIs Gardnerella vaginalis part of a healthy vaginal microbiome?\u003c\/h3\u003e\n\u003cp\u003eNo. G. vaginalis is not found in healthy prepubertal girls, and it is present in nearly 100% of women with clinically diagnosed BV. It can sometimes be found in women without BV, but that likely represents asymptomatic infection, just like other sexually transmitted infections.\u003c\/p\u003e\n\u003ch3\u003eAre women who have sex with women at higher risk for BV?\u003c\/h3\u003e\n\u003cp\u003eYes, BV appears more common among women who have sex with women than in heterosexual women. This is likely because exchanging vaginal fluid is a more efficient way to transmit G. vaginalis. Safer-sex practices between female partners may help reduce this risk.\u003c\/p\u003e\n\u003ch3\u003eShould my partner be treated if I have BV?\u003c\/h3\u003e\n\u003cp\u003eBecause BV is sexually transmitted, treating only you might lead to reinfection from an untreated partner. The article suggests that partner treatment may need to be reconsidered. You may want to discuss BV with your healthcare provider as a potentially sexually transmitted condition that might merit partner evaluation.\u003c\/p\u003e\n\u003ch3\u003eWhen should I seek a second opinion for recurring bacterial vaginosis?\u003c\/h3\u003e\n\u003cp\u003eIf your bacterial vaginosis keeps returning after treatment, a second opinion is worth considering. Recurrence is common because Gardnerella vaginalis creates a biofilm that standard antibiotics may not fully eradicate, and the infection can be sexually transmitted, meaning an untreated partner may cause reinfection. A specialist can review your history and discuss whether biofilm-disrupting therapy, extended regimens, or partner evaluation is appropriate for your situation. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal Article Title:\u003c\/strong\u003e Gardnerella Bacterial Vaginosis\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e \u003ca href=\"https:\/\/doi.org\/10.1093\/infdis\/jiu089\" target=\"_blank\" rel=\"noopener\"\u003e10.1093\/infdis\/jiu089\u003c\/a\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Jane R. Schwebke, MD (Department of Medicine, University of Alabama at Birmingham); Christina A. Muzny, MD (Department of Medicine, University of Alabama at Birmingham); and William E. Josey, MD (Department of Gynecology and Obstetrics, Emory University, Atlanta, Georgia)\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e The Journal of Infectious Diseases 2014;210:338–43\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePublication Details:\u003c\/strong\u003e Received December 16, 2013; accepted February 3, 2014; electronically published February 7, 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. DOI: 10.1093\/infdis\/jiu089\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e This patient-friendly article is based on peer-reviewed research. All authors reported no conflicts of interest. Dr. Charles Rivers assisted with graphics for the original manuscript.\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47541991112860,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/diagnosticdetectives.com\/products\/understanding-bacterial-vaginosis-how-one-bacterium-gardnerella-vaginalis-starts-the-infection","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}